SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2
Katherine M. LittlefieldRenée O. WatsonJennifer M. SchneiderC. Preston NeffEiko YamadaMin ZhangThomas CampbellMichael T. FaltaSarah E. JolleyAndrew P. FontenotBrent E. Palmer
89
Citation
58
Reference
10
Related Paper
Citation Trend
Abstract:
As of January 2022, at least 60 million individuals are estimated to develop post-acute sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While elevated levels of SARS-CoV-2-specific T cells have been observed in non-specific PASC, little is known about their impact on pulmonary function which is compromised in the majority of these individuals. This study compares frequencies of SARS-CoV-2-specific T cells and inflammatory markers with lung function in participants with pulmonary PASC and resolved COVID-19 (RC). Compared to RC, participants with respiratory PASC had between 6- and 105-fold higher frequencies of IFN-γ- and TNF-α-producing SARS-CoV-2-specific CD4+ and CD8+ T cells in peripheral blood, and elevated levels of plasma CRP and IL-6. Importantly, in PASC participants the frequency of TNF-α-producing SARS-CoV-2-specific CD4+ and CD8+ T cells, which exhibited the highest levels of Ki67 indicating they were activity dividing, correlated positively with plasma IL-6 and negatively with measures of lung function, including forced expiratory volume in one second (FEV1), while increased frequencies of IFN-γ-producing SARS-CoV-2-specific T cells associated with prolonged dyspnea. Statistical analyses stratified by age, number of comorbidities and hospitalization status demonstrated that none of these factors affect differences in the frequency of SARS-CoV-2 T cells and plasma IL-6 levels measured between PASC and RC cohorts. Taken together, these findings demonstrate elevated frequencies of SARS-CoV-2-specific T cells in individuals with pulmonary PASC are associated with increased systemic inflammation and decreased lung function, suggesting that SARS-CoV-2-specific T cells contribute to lingering pulmonary symptoms. These findings also provide mechanistic insight on the pathophysiology of PASC that can inform development of potential treatments to reduce symptom burden.Keywords:
Coronavirus
Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19) - Volume 43 Issue 9
Coronavirus
Betacoronavirus
2019-20 coronavirus outbreak
Cite
Citations (2)
The sequences of spike glycoprotein genes of six human coronavirus strains,five avian infectious bronchitis virus strains,four murine hepatitis virus strains,seven bovine coronavirus strains,two feline coronavirus strains,nine porcine coronavirus strains (epidemic diarrhea virus,transmissible gastroenteritis virus),four canine coronavirus strains and five SARS coronavirus strains were compared by software DNAstar.It is shown that the sequence consensus of human coronavirus spike glycoprotein genes is 27.2%～99.5%;that of avian infectious bronchitis viruses is 81.5%～100%;of feline coronavirus strains is 79.5%～89.6%;of bovine coronavirus strains is 97.7%～100%;of canine coronavirus strains is 64.9%～98.8%;of SARS-related coronavirus is 99.9%～100%.The sequence consensus of spike glycoprotein genes of SARS coronavirus strains compared with forty-two other coronavirus strains is lower than 30.8%,which indicates that SARS-related coronavirus might not evolve from the other kind of viruses,but it is a new kind of virus that humankind has never touched before.
Coronavirus
Bovine coronavirus
Coronaviridae
Mouse hepatitis virus
Nidovirales
Cite
Citations (0)
The emergence of a novel coronavirus (2019-nCoV) has awakened the echoes of SARS-CoV from nearly two decades ago. Yet, with technological advances and important lessons gained from previous outbreaks, perhaps the world is better equipped to deal with the most recent emergent group 2B coronavirus.
Coronavirus
2019-20 coronavirus outbreak
Betacoronavirus
Coronavirus Infections
Pandemic
Cite
Citations (1,377)
COVID-19 is caused by the virus SARS-CoV-2 that belongs to the Coronaviridae groups. The subgroups of the coronavirus families are α , β , γ , and δ coronavirus (the four general human coronaviruses). Representative coronaviruses consist of NL63 coronavirus (human) and porcine transmissible gastroenteritis from the Alphacoronavirus genus; mouse hepatitis coronavirus (MHV), bovine coronavirus (BCoV), severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV); avian infectious bronchitis virus (IBV); and porcine δ -coronavirus (PdCoV). This work exhibits, δ -coronavirus spikes are fundamentally and evolutionally more similar related to α -coronavirus spikes than to β -coronavirus or γ -coronavirus spikes due to the receptor recognition, membrane fusion phenomenon, and immune evasion behavior.
Coronavirus
Coronaviridae
Bovine coronavirus
Mouse hepatitis virus
Betacoronavirus
Cite
Citations (3)
Antisera prepared against each of three single and one pair of major structural proteins of the bovine coronavirus (Mebus strain) were used in immunoblotting studies to measure cross-reactivity with the structural proteins of the human coronavirus OC43 and the mouse hepatitis coronavirus A59. We conclude that the bovine coronavirus is comprised of four major structural proteins, gp190 (normally present as 120- and 100-kilodalton subunits), gp140, pp52, and gp26. The human coronavirus OC43 has an antigenically homologous counterpart of similar molecular mass to each of these proteins. The mouse hepatitis coronavirus A59 has an antigenically homologous counterpart to only three of these proteins: gp190, pp52 and gp26. There is no counterpart in the mouse virus to the 140-kilodalton glycoprotein, the apparent hemagglutinin of the bovine coronavirus.
Coronavirus
Bovine coronavirus
Mouse hepatitis virus
Coronaviridae
Betacoronavirus
Cite
Citations (94)
This study summarized the determination methods and principles of 2019 novel coronavirus(severe acute respiratory syndrome coronavirus 2,SARS-CoV-2). The advantages and limitations of several methods was compared, which can provide a basis for the selection of 2019 novel coronavirus clinical diagnosis methods.
Coronavirus
2019-20 coronavirus outbreak
Sars virus
Betacoronavirus
Coronavirus Infections
Cite
Citations (0)
The outbreak of SARS-CoV-2 rapidly spread across China and worldwide. Remdesivir had been proposed as a promising option for treating coronavirus disease 2019 (COVID-19). We provided a rapid review to critically assess the potential anti-coronavirus effect of remdesivir on COVID-19 and other coronaviruses based on the most up-to-date evidence. Even though remdesivir was proposed as a promising option for treating COVID-19 based on laboratory experiments and reports from compassionate use, its safety and effect in humans requires high-quality evidence from well-designed and adequately-powered clinical trials for further clarification.
Coronavirus
2019-20 coronavirus outbreak
Betacoronavirus
Cite
Citations (63)
Coronavirus tropism is predominantly determined by the interaction between coronavirus spikes and the host receptors. In this regard, coronaviruses have evolved a complicated receptor-recognition system through their spike proteins. Spikes from highly related coronaviruses can recognize distinct receptors, whereas spikes of distant coronaviruses can employ the same cell-surface molecule for entry. Moreover, coronavirus spikes can recognize a broad range of cell-surface molecules in addition to the receptors and thereby can augment coronavirus attachment or entry. The receptor of Middle East respiratory syndrome coronavirus (MERS-CoV) is dipeptidyl peptidase 4 (DPP4). In this study, we identified membrane-associated 78-kDa glucose-regulated protein (GRP78) as an additional binding target of the MERS-CoV spike. Further analyses indicated that GRP78 could not independently render nonpermissive cells susceptible to MERS-CoV infection but could facilitate MERS-CoV entry into permissive cells by augmenting virus attachment. More importantly, by exploring potential interactions between GRP78 and spikes of other coronaviruses, we discovered that the highly conserved human GRP78 could interact with the spike protein of bat coronavirus HKU9 (bCoV-HKU9) and facilitate its attachment to the host cell surface. Taken together, our study has identified GRP78 as a host factor that can interact with the spike proteins of two Betacoronaviruses, the lineage C MERS-CoV and the lineage D bCoV-HKU9. The capacity of GRP78 to facilitate surface attachment of both a human coronavirus and a phylogenetically related bat coronavirus exemplifies the need for continuous surveillance of the evolution of animal coronaviruses to monitor their potential for human adaptations.
Coronavirus
Bovine coronavirus
Tissue tropism
Lineage (genetic)
Betacoronavirus
Cite
Citations (185)
Coronavirus
Mouse hepatitis virus
Coronaviridae
Betacoronavirus
spike protein
Cite
Citations (20)